IP Library › Granted Patent US 10,752,622
Granted Patent B2
US 10,752,622 · App. 16/231,791 · Granted Aug 25, 2020

GPR119 agonist compounds

Inventors: Rakesh Ishwar Patil (IMT Manesar, IN); Jeevan Verma (IMT Manesar, IN); Puneet Kumar (IMT Manesar, IN); Amol Pandurang Gunjal (IMT Manesar, IN); Himanshu Rai (IMT Manesar, IN); Santosh Kumar Rai (IMT Manesar, IN); Anil Kumar (IMT Manesar, IN)
Assignee: MANKIND PHARMA LTD.
C07D417/14C07D513/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,752,622
App. No.
16/231,791
Granted
Aug 25, 2020
Kind
B2
Abstract

The present invention relates to novel compounds of formula (I), process for preparation of the same and composition comprising these compounds.

Claims (6)

1. A compound which is 2-((S)-1-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)ethoxy)-6-(2-fluoro-4-(methylsulfonyl)phenyl)imidazo[2,1-b][1,3,4]thiadiazole represented by the following structural formula:

or a physiologically acceptable salt thereof.

2. A method of treating diseases and conditions mediated through GPR119 to a patient in need thereof comprising administering the compound which is 2-((S)-1-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)ethoxy)-6-(2-fluoro-4-(methylsulfonyl)phenyl)imidazo[2,1-b][1,3,4]thiadiazole represented by the following structural formula:

3. The method of claim 2 , wherein said disease is metabolic disorder.

4. The method of claim 3 , wherein said disease is diabetes.

5. The method of claim 4 , wherein said disease is Type II diabetes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2019
From: PATIL, RAKESH ISHWAR; VERMA, JEEVAN; KUMAR, PUNEET; GUNJAL, AMOL PANDURANG; RAI, HIMANSHU; RAI, SANTOSH KUMAR; KUMAR, ANIL
To: MANKIND PHARMA LTD.
Reel/Frame 049093/0424 →
Priority Claims (1)
IN 201611012426 · Apr 8, 2016 · national
Continuity (2)
Continuation 15478930 · Apr 4, 2017
Related Publication 20190127363A1 · May 2, 2019